FDA approves Bristol Myers Squibb’s Subcutaneous Opdivo Qvantig™ for various solid tumor indications
December 2024- Bristol Myers Squibb announced that the U.S. Food and Drug…
Bristol Myers Squibb Collaborates for 4th Blood Donation Drive in Dubai
Dubai, UAE- 01 October 2024- In a notable effort to highlight the…
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients
Princeton- May 2024- Bristol Myers Squibb announced ASPIRE (Accessibility, Sustainability, Patient-centric, Impact,…
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
PRINCETON- March 2024- Bristol Myers Squibb unveiled a $1.8 million initiative to…